[LIVE TRADE DAY] AMZN- Relative Strength After Announcing 2nd Prime Day in 1 Year for First Time Ever

[Manage your email subscriptions.]( Good morning, Trader! Here are our top 4 trade ideas today. These setups look primed! Be the best prepared trader on the Street!  - [MyMD Pharmaceuticals, Inc. (MYMD)*](- MYMD Up 20% in 1 day, Holds Gains on Increased Volume - NMTR- 25% Higher After Positive Phase 2 Results - AMZN- Relative Strength After Announcing 2nd Prime Day in 1 Year for First Time Ever - WYNN - 2nd Day Play After Macau Authorities Announce Plans to Welcome Back Tour Groups *This is an Issuer-Paid Advertisement, See Disclosure Below  Sponsored By [MyMD Pharmaceuticals, Inc. (MYMD)*](- MYMD Up Nearly 20% in 1 day, Holds Gains on Increased Volume After Breaking Below $3 support, in the weak overall market environment, there was some major selling in [MYMD]( testing the resolve of investors and short term traders in the company. Well, when there is panic, that presents opportunities for participants to get in at favorable prices. That’s what we saw yesterday, when buyers emerged, and drove [MYMD]( up nearly 20% on heavy volume.  We’ve been telling you about this potential move for about a week now, as [MYMD]( has historically not stayed below $3 for long. Most importantly yesterday’s move was made on Increased volume, that’s a good sign moving forward as that could be the mark of a larger reversal to come. If the bottom is in the next logical target is a test of $3, above that, there is a gap to fill at $3.50. To the downside there is potential support at $2.50, below that a gap to fill at $2.22. [MyMD Pharmaceuticals, Inc. (MYMD)*]( is a clinical-stage pharmaceutical company that develops drug products targeting aging, age-related, and autoimmune diseases. [Click Here To FInd Out More About the Company Working to Significantly Increase Lifespan](  *This is an Issuer-Paid Advertisement, See Disclosure Below  Terminator Trades Enrollment Will Be Reopening This Week  Stay tuned for an important announcement about how to get access to this limited-time, limited-seats opportunity. Once it's done, it will be a while before you will be able to access Ben Sturgill’s most POWERFUL Trading Project!  NMTR- 25% Higher After Positive Phase 2 Results 9 Meters Biopharma announced positive results for its drug dealing with Short Bowel Syndrome (SBS). It’s gapping 25% higher on the news. This is a very low priced penny stock, so the most important thing here is volume. To the upside the first target is 0.30, then 0.40 and there is a gap to fill at 0.51 if things really get going today. If the stock fails, it's likely to trade as low as 0.21 today. Don’t miss our expert traders in the[360 Wall Street Chat Room]( as they alert their best trade ideas in real time!  AMZN- Relative Strength After Announcing 2nd Prime Day in 1 Year for First Time Ever AMZN announced it would hold a 2nd prime day in October for subscribers. Despite a weak market yesterday, AMZN finished green on the news and is gapping higher with the QQQ’s this morning.  To the upside, yesterday's high of 117.34 is the first test. Above that, the next targets to the upside are 118.79 and then 120. To the downside there is a gap to fill at 115.15 which was yesterday's close and then 113.13 below that. [Here is your direct link to the 360 Wall Street Chat Room](  WYNN - 2nd Day Play After Macau Authorities Announce Plans to Welcome Back Tour Groups Wynn outperformed the market yesterday, trading on independent order-flow due to the news. Lockdowns due to China’s 0 Covid policy in Macau have put pressure on revenues for gaming companies and casinos. The announcement that tour groups from China’s mainland are set to return should help top-line revenue moving forward. For this reason, buyers returned to the gaming sector after it had been beaten down for months.  To the upside, yesterday’s high of $68.89 is the first test, above that we have $70 and $72. Potential support is at $64. [Here is your direct link to the 360 Wall Street Chat Room](  To Your Success! 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360.com](  © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions  *THIS IS AN ISSUER-PAID ADVERTISEMENT, SEE DISCLOSURE BELOW*ISSUER-PAID ADVERTISEMENT. MyMD, Inc. (“MYMD” or the “Company”) HAS PAID ORWILL PAY SHERWOOD VENTURES, LLC (“Sherwood”) TWENTY-THOUSAND DOLLARS USD PER MONTH FOR THREE MONTHS (THE “INITIAL TERM”) IN CASH, SHARES OF RESTRICTED COMMON STOCK WITH A VALUE OF ONE-HUNDRED-FIFTY THOUSAND DOLLARS, AND WARRANTS VALUED AT ISSUANCE OF SEVENTY-FIVE THOUSAND DOLLARS FOR MARKETING SERVICES INCLUDING COMMUNICATING TO THE PUBLIC ABOUT THE COMPANY THROUGH SHERWOOD’S AFFILIATE RAGINGBULL.COM, LLC (“RAGING BULL”), AMONG OTHERS. THIS ADVERTISEMENT IS PART OF THOSE ISSUER-PAID MARKETING SERVICES. FOR DETAILED COMPENSATION AND MORE INFORMATION, PLEASE SEE THE FULL DISCLOSURE LOCATED AT HTTPS://BOARDROOMINVESTING.COM/MYMD-DISCLAIMER. DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [RagingBull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.